| Analysis | Metabolite Name | Measured Value | Units | Genotype | TREATMENT | TIME_POINT |
|---|---|---|---|---|---|---|
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.22794095 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.590917961 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.601120499 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.697965141 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.707921543 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.70802613 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.738407629 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.74276325 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.747319388 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.784498143 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.823838451 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.849538362 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.854305461 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.864604256 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.867306775 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.911187254 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.91239203 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.915160295 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.967529124 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 0.973756394 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.001010952 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.026010231 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.032811144 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.047052568 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.096054207 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.100243613 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.139035583 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.164809506 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.172642879 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.198635062 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.214302295 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.220060857 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.284994286 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.307323881 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.408445562 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.420157509 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 1.673762554 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 2.122497633 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | sphingomyelin (d18:1/20:0, d16:1/22:0)* | 2.348125842 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|